Income Statement Chugai Pharmaceutical Co., Ltd.

Equities

4519

JP3519400000

Pharmaceuticals

Market Closed - Japan Exchange Other stock markets 06:30:00 13/02/2026 GMT			5-day change	1st Jan Change
9,280.00 ^JPY	+0.87%		+7.81%	+12.58%

02-06	Japan's Nikkei rallies on earnings in unsteady trade before Sunday election	RE
02-06	Japanese drugmakers slump after Trump unveils discount drug website	RE

22f8ebc4b726343cca0f0e95ef6.urkPS3wfPCn-zc4HiuZNcy1r1DwKbWinykWKXkvndcE.gvNVDh1wb1PKoKtAv4wCHhsegklEFALi8w7PAT2qLKiN9GRzNk8OGoa3hw

Published financial data: CHUGAI PHARMACEUTICAL CO., LTD.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	633B	803B	1,039B	974B	998B
Other Revenues, Total	154B	197B	221B	137B	173B
Total Revenues	787B	1T	1,260B	1,111B	1,171B
Cost of Goods Sold, Total	273B	338B	476B	413B	339B
Gross Profit	513B	662B	784B	698B	831B
Selling General & Admin Expenses, Total	94.4B	102B	101B	113B	110B
R&D Expenses	118B	137B	150B	175B	181B
Other Operating Expenses	-	-	-	-28.56B	-2.34B
Other Operating Expenses, Total	212B	240B	250B	259B	289B
Operating Income	301B	422B	533B	439B	542B
Interest Expense, Total	-62M	-48M	-61M	-27M	5M
Interest And Investment Income	-	-	52M	4.67B	1.03B
Net Interest Expenses	-62M	-48M	-9M	4.65B	1.03B
Other Non Operating Income (Expenses)	-2.98B	-2.46B	-2.13B	-	-1M
EBT, Excl. Unusual Items	298B	419B	531B	444B	543B
EBT, Incl. Unusual Items	298B	419B	531B	444B	543B
Income Tax Expense	83.46B	116B	157B	118B	156B
Earnings From Continuing Operations	215B	303B	374B	325B	387B
Net Income to Company	215B	303B	374B	325B	387B
Minority Interest	-	-	-	-	-
Net Income - (IS)	215B	303B	374B	325B	387B
Net Income to Common Incl Extra Items	215B	303B	374B	325B	387B
Net Income to Common Excl. Extra Items	215B	303B	374B	325B	387B
Per Share Items
Net EPS - Basic	130.66	184.29	227.64	197.83	235.39
Basic EPS - Continuing Operations	130.66	184.29	227.64	197.83	235.39
Basic Weighted Average Shares Outstanding	1.64B	1.64B	1.64B	1.65B	1.65B
Net EPS - Diluted	130.53	184.17	227.57	197.8	235.36
Diluted EPS - Continuing Operations	130.53	184.17	227.57	197.8	235.36
Diluted Weighted Average Shares Outstanding	1.65B	1.65B	1.65B	1.65B	1.65B
Normalized Basic EPS	113.4	159.42	201.84	168.6	206.26
Normalized Diluted EPS	113.29	159.32	201.77	168.57	206.24
Dividend Per Share	55	76	78	80	98
Payout Ratio	42.58	32.56	36.91	40.43	34.4
American Depositary Receipts Ratio (ADR)	0.5	0.5	0.5	0.5	0.5
Supplemental Items
EBITDA	332B	453B	565B	471B	574B
EBITA	301B	422B	533B	439B	542B
EBIT	301B	422B	533B	439B	542B
Effective Tax Rate - (Ratio)	27.99	27.75	29.51	26.67	28.68
Normalized Net Income	186B	262B	332B	277B	339B
Non-Cash Pension Expense	26M	-1M	2M	-55M	-100M
Supplemental Operating Expense Items
Selling and Marketing Expenses	72.58B	76.59B	77.15B	-	-
General and Administrative Expenses	21.82B	25.82B	23.61B	-	-
Research And Development Expense From Footnotes	114B	130B	144B	163B	177B

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	212B	268B	222B	459B	540B
Short Term Investments	166B	204B	281B	280B	456B
Total Cash And Short Term Investments	379B	472B	503B	739B	996B
Accounts Receivable, Total	253B	355B	513B	319B	334B
Other Receivables	12M	928M	1.74B	1.46B	896M
Total Receivables	253B	356B	514B	320B	335B
Inventory	184B	209B	292B	273B	240B
Prepaid Expenses	15B	17.3B	18.77B	21.83B	23.01B
Other Current Assets, Total	4.04B	9.54B	8.17B	11.79B	11.47B
Total Current Assets	835B	1,064B	1,337B	1,366B	1,606B
Net Property Plant And Equipment	297B	352B	387B	421B	442B
Long-term Investments	31.29B	44.66B	56.18B	61.09B	73.07B
Other Intangibles, Total	23.88B	21.97B	25.14B	19.86B	17.87B
Deferred Tax Assets Long-Term	47.93B	56.29B	65.24B	64.47B	69.84B
Other Long-Term Assets, Total	1M	2M	-	-	-
Total Assets	1,235B	1,539B	1,870B	1,933B	2,208B
Liabilities
Accounts Payable, Total	100B	152B	210B	112B	65.35B
Accrued Expenses, Total	31.58B	34.42B	37.75B	44.63B	49.32B
Short-term Borrowings	-	-	-	-	-
Current Portion of Leases	6.65B	6.55B	6.43B	6.98B	6.36B
Current Income Taxes Payable	83.31B	108B	121B	71.57B	142B
Unearned Revenue Current, Total	80M	86M	79M	31M	31M
Other Current Liabilities	14.06B	25.81B	48.47B	52.54B	26.78B
Total Current Liabilities	236B	327B	424B	288B	290B
Long-Term Debt	-	-	-	-	-
Long-Term Leases	4.64B	9.49B	7.68B	6.48B	4.53B
Pension & Other Post Retirement Benefits	2.28B	2.94B	3.31B	3.15B	3.94B
Deferred Tax Liability Non Current	9.17B	7.61B	7.09B	5.79B	5.08B
Other Non Current Liabilities	3.34B	3.21B	3.57B	3.34B	2.97B
Total Liabilities	255B	351B	445B	307B	307B
Common Stock, Total	73.2B	73.2B	73.2B	73.2B	73.2B
Additional Paid In Capital	67.59B	68.22B	68.81B	69.36B	69.9B
Retained Earnings	849B	1,054B	1,293B	1,489B	1,747B
Comprehensive Income and Other	-9.88B	-7.46B	-10.97B	-5.72B	11.47B
Total Common Equity	980B	1,188B	1,424B	1,626B	1,901B
Minority Interest	-	-	-	-	-
Total Equity	980B	1,188B	1,424B	1,626B	1,901B
Total Liabilities And Equity	1,235B	1,539B	1,870B	1,933B	2,208B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	1.64B	1.64B	1.65B	1.65B	1.65B
ECS Total Common Shares Outstanding	1.64B	1.64B	1.65B	1.65B	1.65B
Book Value / Share	596.16	722.5	865.88	988.01	1.16K
Tangible Book Value	956B	1,166B	1,399B	1,606B	1,884B
Tangible Book Value Per Share	581.63	709.13	850.59	975.94	1.14K
Total Debt	11.28B	16.04B	14.11B	13.46B	10.9B
Net Debt	-367B	-456B	-489B	-726B	-985B
Debt Equivalent of Unfunded Proj. Benefit Obligation	1.79B	1.62B	-1.86B	-4.34B	-10.04B
Minority Interest, Total (Incl. Fin. Div)	-	-	-	-	-
Full Time Employees	7.56K	7.66K	7.77K	7.6K	5.03K
Accumulated Allowance for Doubtful Accounts (Supple)	13M	17M	20M	23M	28M

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	215B	303B	374B	325B	387B
Depreciation & Amortization - CF	30.38B	30.87B	31.43B	31.74B	31.66B
Depreciation & Amortization, Total	30.38B	30.87B	31.43B	31.74B	31.66B
(Gain) Loss From Sale Of Asset	953M	6.34B	641M	-21.88B	4.38B
Other Operating Activities, Total	-65.25B	-104B	-152B	-181B	-102B
Change in Other Net Operating Assets	24.22B	43.52B	-10.32B	255B	126B
Cash from Operations	205B	280B	244B	410B	448B
Capital Expenditure	-57.04B	-65.97B	-62.62B	-71.95B	-50.42B
Sale of Property, Plant, and Equipment	-22M	1.04B	1.05B	19.35B	-510M
Sale (Purchase) of Intangible assets	-4.35B	-6.9B	-8.61B	12.85B	-1.68B
Investment in Marketable and Equity Securities, Total	-37B	-47.24B	-76.08B	979M	-178B
Other Investing Activities, Total	100M	133M	280M	1.48B	2.78B
Cash from Investing	-98.31B	-119B	-146B	-37.29B	-227B
Issuance of Common Stock	440M	322M	241M	217M	168M
Repurchase of Common Stock	-30M	-8M	-5M	-5M	-10M
Common Dividends Paid	-91.44B	-98.64B	-138B	-132B	-133B
Common & Preferred Stock Dividends Paid	-91.44B	-98.64B	-138B	-132B	-133B
Other Financing Activities, Total	-8.46B	-9.08B	-7.66B	-7.95B	-7.92B
Cash from Financing	-99.5B	-107B	-146B	-139B	-141B
Foreign Exchange Rate Adjustments	1.17B	2.13B	1.94B	3.2B	2.3B
Miscellaneous Cash Flow Adjustments	1M	-	-	-1M	-
Net Change in Cash	8.39B	55.42B	-45.58B	237B	81.53B
Supplemental Items
Cash Interest Paid	34M	48M	58M	81M	94M
Cash Income Tax Paid (Refund)	66.78B	104B	152B	176B	100B
Levered Free Cash Flow	125B	178B	148B	317B	339B
Unlevered Free Cash Flow	125B	178B	148B	317B	339B
Change In Net Working Capital	32.25B	43.95B	145B	-69.93B	-20.5B

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	16.41	19.01	19.56	14.44	16.36
Return on Total Capital	20.27	24.02	25.23	17.84	19.08
Return On Equity %	23.42	27.95	28.67	21.34	21.96
Return on Common Equity	23.42	27.95	28.67	21.34	21.96
Margin Analysis
Gross Profit Margin %	65.25	66.18	62.2	62.81	71.01
SG&A Margin	12	10.24	8	10.13	9.41
EBITDA Margin %	42.14	45.29	44.82	42.37	49.01
EBITA Margin %	38.28	42.2	42.33	39.52	46.3
EBIT Margin %	38.28	42.2	42.33	39.52	46.3
Income From Continuing Operations Margin %	27.29	30.31	29.72	29.29	33.09
Net Income Margin %	27.29	30.31	29.72	29.29	33.09
Net Avail. For Common Margin %	27.29	30.31	29.72	29.29	33.09
Normalized Net Income Margin	23.68	26.22	26.35	24.96	28.99
Levered Free Cash Flow Margin	15.88	17.77	11.76	28.53	28.94
Unlevered Free Cash Flow Margin	15.89	17.78	11.76	28.53	28.94
Asset Turnover
Asset Turnover	0.69	0.72	0.74	0.58	0.57
Fixed Assets Turnover	2.8	3.08	3.41	2.75	2.72
Receivables Turnover (Average Receivables)	2.91	2.64	2.4	2.34	3.06
Inventory Turnover (Average Inventory)	1.55	1.72	1.9	1.46	1.32
Short Term Liquidity
Current Ratio	3.54	3.25	3.15	4.74	5.53
Quick Ratio	2.68	2.53	2.4	3.68	4.59
Operating Cash Flow to Current Liabilities	0.87	0.85	0.58	1.42	1.54
Days Sales Outstanding (Average Receivables)	125.69	138.31	152.36	155.71	119.78
Days Outstanding Inventory (Average Inventory)	235.56	211.96	192	249.78	276.89
Average Days Payable Outstanding	112.64	126.99	118.09	149.07	106.34
Cash Conversion Cycle (Average Days)	248.62	223.27	226.27	256.42	290.32
Long Term Solvency
Total Debt/Equity	1.15	1.35	0.99	0.83	0.57
Total Debt / Total Capital	1.14	1.33	0.98	0.82	0.57
LT Debt/Equity	0.47	0.8	0.54	0.4	0.24
Long-Term Debt / Total Capital	0.47	0.79	0.53	0.4	0.24
Total Liabilities / Total Assets	20.68	22.79	23.82	15.88	13.9
EBIT / Interest Expense	4.86K	8.79K	8.74K	16.27K	-108K
EBITDA / Interest Expense	5.35K	9.43K	9.26K	17.44K	-115K
(EBITDA - Capex) / Interest Expense	4.43K	8.06K	8.23K	14.78K	-105K
Total Debt / EBITDA	0.03	0.04	0.02	0.03	0.02
Net Debt / EBITDA	-1.11	-1.01	-0.87	-1.54	-1.72
Total Debt / (EBITDA - Capex)	0.04	0.04	0.03	0.03	0.02
Net Debt / (EBITDA - Capex)	-1.34	-1.18	-0.97	-1.82	-1.88
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	14.68	27.04	26.02	-11.79	5.33
Gross Profit, 1 Yr. Growth %	22.22	28.85	18.45	-10.93	19.07
EBITDA, 1 Yr. Growth %	39.92	36.54	24.73	-16.61	21.82
EBITA, 1 Yr. Growth %	43.04	40.06	26.41	-17.65	23.41
EBIT, 1 Yr. Growth %	43.04	40.06	26.41	-17.65	23.41
Earnings From Cont. Operations, 1 Yr. Growth %	36.29	41.1	23.58	-13.08	19
Net Income, 1 Yr. Growth %	36.29	41.1	23.58	-13.08	19
Normalized Net Income, 1 Yr. Growth %	43.43	40.64	26.65	-16.44	22.35
Diluted EPS Before Extra, 1 Yr. Growth %	36.24	41.09	23.57	-13.08	18.99
Accounts Receivable, 1 Yr. Growth %	39.47	40.16	44.34	-37.78	4.82
Inventory, 1 Yr. Growth %	9.38	13.56	39.92	-6.41	-12.22
Net Property, Plant and Equip., 1 Yr. Growth %	12.13	18.36	9.81	8.81	4.96
Total Assets, 1 Yr. Growth %	16.68	24.54	21.52	3.36	14.27
Tangible Book Value, 1 Yr. Growth %	15.13	21.96	20	14.76	17.31
Common Equity, 1 Yr. Growth %	14.76	21.23	19.9	14.12	16.97
Cash From Operations, 1 Yr. Growth %	-0.78	36.38	-12.7	67.92	9.19
Capital Expenditures, 1 Yr. Growth %	7.6	15.65	-5.07	14.89	-29.93
Levered Free Cash Flow, 1 Yr. Growth %	6.12	42.2	-16.63	113.99	6.87
Unlevered Free Cash Flow, 1 Yr. Growth %	6.08	42.18	-16.62	113.94	6.86
Dividend Per Share, 1 Yr. Growth %	71.88	38.18	2.63	2.56	22.5
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	16.5	20.71	26.53	5.43	-3.61
Gross Profit, 2 Yr. CAGR %	27.28	25.49	23.54	2.72	2.99
EBITDA, 2 Yr. CAGR %	53.41	38.22	30.5	1.98	0.79
EBITA, 2 Yr. CAGR %	55.66	41.54	33.06	2.03	0.81
EBIT, 2 Yr. CAGR %	55.66	41.54	33.06	2.03	0.81
Earnings From Cont. Operations, 2 Yr. CAGR %	51.89	38.67	32.05	3.64	1.71
Net Income, 2 Yr. CAGR %	52.37	38.67	32.05	3.64	1.71
Normalized Net Income, 2 Yr. CAGR %	57.31	42.03	33.47	2.87	1.11
Diluted EPS Before Extra, 2 Yr. CAGR %	52.31	38.64	32.04	3.63	1.7
Accounts Receivable, 2 Yr. CAGR %	18.78	39.82	42.24	-5.23	-19.24
Inventory, 2 Yr. CAGR %	7.42	11.45	26.06	14.43	-9.36
Net Property, Plant and Equip., 2 Yr. CAGR %	15.66	15.2	14	9.31	6.86
Total Assets, 2 Yr. CAGR %	15.91	20.54	23.02	12.07	8.68
Tangible Book Value, 2 Yr. CAGR %	14.2	18.5	20.97	17.35	16.02
Common Equity, 2 Yr. CAGR %	13.87	17.95	20.56	16.97	15.54
Cash From Operations, 2 Yr. CAGR %	31.22	16.33	9.11	21.08	35.41
Capital Expenditures, 2 Yr. CAGR %	-10.86	11.56	4.78	4.43	-10.28
Levered Free Cash Flow, 2 Yr. CAGR %	91.16	22.84	8.88	33.57	51.22
Unlevered Free Cash Flow, 2 Yr. CAGR %	90.99	22.81	8.88	33.56	51.2
Dividend Per Share, 2 Yr. CAGR %	38.51	54.11	19.09	2.6	12.09
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	13.78	19.92	22.45	12.19	5.4
Gross Profit, 3 Yr. CAGR %	22.4	27.8	23.1	10.78	7.9
EBITDA, 3 Yr. CAGR %	42.22	47.57	33.57	12.4	8.21
EBITA, 3 Yr. CAGR %	44.94	50.27	36.3	13.39	8.71
EBIT, 3 Yr. CAGR %	44.94	50.27	36.3	13.39	8.71
Earnings From Cont. Operations, 3 Yr. CAGR %	42.93	48.2	33.45	14.87	8.53
Net Income, 3 Yr. CAGR %	43.47	48.52	33.45	14.87	8.53
Normalized Net Income, 3 Yr. CAGR %	46.05	51.54	36.71	14.18	8.99
Diluted EPS Before Extra, 3 Yr. CAGR %	43.39	48.48	33.42	14.86	8.52
Accounts Receivable, 3 Yr. CAGR %	13.28	25.52	41.31	7.97	-1.99
Inventory, 3 Yr. CAGR %	2.84	9.43	20.23	14.14	4.75
Net Property, Plant and Equip., 3 Yr. CAGR %	20.14	16.55	13.38	12.24	7.84
Total Assets, 3 Yr. CAGR %	13.17	18.72	20.87	16.08	12.8
Tangible Book Value, 3 Yr. CAGR %	12.54	16.73	18.99	18.86	17.33
Common Equity, 3 Yr. CAGR %	12.3	16.27	18.59	18.38	16.97
Cash From Operations, 3 Yr. CAGR %	23.97	32.92	5.71	25.98	16.98
Capital Expenditures, 3 Yr. CAGR %	20.16	-2.78	5.71	8.05	-8.57
Levered Free Cash Flow, 3 Yr. CAGR %	35.31	73.2	7.95	36.39	24
Unlevered Free Cash Flow, 3 Yr. CAGR %	35.27	73.1	7.94	36.37	23.99
Dividend Per Share, 3 Yr. CAGR %	38.58	38.4	34.58	13.3	8.84
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	9.55	15.25	18.72	13.9	11.27
Gross Profit, 5 Yr. CAGR %	14.7	22.1	22.85	17.11	14.62
EBITDA, 5 Yr. CAGR %	26.5	37.16	37.41	27.29	19.34
EBITA, 5 Yr. CAGR %	28.26	40.56	40.06	28.71	20.81
EBIT, 5 Yr. CAGR %	28.26	40.56	40.06	28.71	20.81
Earnings From Cont. Operations, 5 Yr. CAGR %	28.06	41	38.47	28.45	19.71
Net Income, 5 Yr. CAGR %	28.57	41.41	38.79	28.61	19.71
Normalized Net Income, 5 Yr. CAGR %	28.44	41.78	40.88	29.79	21.17
Diluted EPS Before Extra, 5 Yr. CAGR %	28.49	41.33	38.74	28.59	19.69
Accounts Receivable, 5 Yr. CAGR %	9.81	16.22	24.08	12.17	12.97
Inventory, 5 Yr. CAGR %	2.68	2.4	11.57	11.41	7.38
Net Property, Plant and Equip., 5 Yr. CAGR %	14.14	17.52	17.65	13.6	10.73
Total Assets, 5 Yr. CAGR %	9.43	13.8	17.01	16.01	15.84
Tangible Book Value, 5 Yr. CAGR %	9.32	13.24	15.84	16.98	17.8
Common Equity, 5 Yr. CAGR %	9.38	12.98	15.54	16.55	17.36
Cash From Operations, 5 Yr. CAGR %	26.65	48.45	17.8	28.05	16.72
Capital Expenditures, 5 Yr. CAGR %	25.44	17	13.75	0.05	-1
Levered Free Cash Flow, 5 Yr. CAGR %	25.14	50.61	24.05	56.11	23.53
Unlevered Free Cash Flow, 5 Yr. CAGR %	25.12	50.68	24.02	56.04	23.52
Dividend Per Share, 5 Yr. CAGR %	25.98	34.4	30.43	22.78	25.09